News Releases

November 3, 2021

Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

October 28, 2021

Pinnacle 21 Awarded FDA Contract for 5 Years for Software and Services

October 25, 2021

Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award

October 19, 2021

Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021

October 12, 2021

Certara Appoints Patrick F. Smith to President of Integrated Drug Development

October 5, 2021

Certara Appoints Drayton T. Virkler as Chief Commercial Officer

October 4, 2021

Certara Completes Acquisition of Pinnacle 21

September 30, 2021

Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process

September 22, 2021

Certara Announces New Clinical Science Group and Adds Senior Scientific Experts

September 20, 2021

Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation